Journals / Trends in pediatrics / 2021 / Cilt: 2 - Sayı: 2

Langerhans Cell Histiocytosis with Isolated Central Diabetes Insipidus, Low Grade Fever and Sellar Erosion

Pages
104–108
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The presence of low-grade fever in a patient presenting with isolated CDI is a warning sign for the diagnosis of LCH.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Langerhans cell histiocytosis (LCH) is a rare disease of the monocyte-macrophage system.
📊
Key Findings & Data:A 4-year-old, 5-month-old male patient who applied to our outpatient clinic was diagnosed with Langerhans cell histiocytosis in further examination after the diagnosis of central diabetes insipidus (CDI) was made.
💡
Conclusion & Impact:The presence of low-grade fever in a patient presenting with isolated CDI is a warning sign for the diagnosis of LCH.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Langerhans cell histiocytosis (LCH) is a rare disease of the monocyte-macrophage system. Although it is known that bone involvement is seen very frequently in cases with LCH, our case is the first case with a lytic-destructive lesion in the bone structure forming sella turcica. A 4-year-old, 5-month-old male patient who applied to our outpatient clinic was diagnosed with Langerhans cell histiocytosis in further examination after the diagnosis of central diabetes insipidus (CDI) was made. On cranial magnetic resonance imaging (MRI), widespread lytic-destructive bone lesions were observed in the bone structure forming the sella (sphenoid bone), sellar destruction not previously described in the literature. Sellar erosion has not been reported before in cases diagnosed with LCH in the literature. The presence of low-grade fever in a patient presenting with isolated CDI is a warning sign for the diagnosis of LCH.

🔖

Cite This Article

Derinkuyu, B. E., Erdeve, Ş. S., Çetinkaya, S., Okur, İ., Arı, H., Çağlar, G., Çınar, H. G., Yeşil, Ş. (2022). Langerhans Cell Histiocytosis with Isolated Central Diabetes Insipidus, Low Grade Fever and Sellar Erosion. Trends in pediatrics, Cilt: 2 - Sayı: 2, 104–108. https://ajindex.com/articles/598908

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Grois N, Fahrner B, Arceci RJ, et al. Central nervous system disease in langerhans cell histiocytosis. J Pediatr. 2010;156:873-81.
  2. Guyot-Goubin A, Donadieu J, Barkaoui M, Bellec S, Thomas C, Clavel J. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000-2004. Pediatr Blood Cancer 2008;51:71-5.
  3. Leung AKC, Lam JM, Leong KF. Childhood Langerhans cell histiocytosis: a disease with many faces. World J Pediatr. 2019;15:536-45.
  4. Maghnie M, Cosi G, Genovese E, et al. Central diabetes insipidus in children and young adults. N Engl J Med. 2000;343:998-1007.
  5. Catlı G, Abacı A, Korcan D, et al. Clinical profile and etiologies of children with central diabetes insipidus: a single-center experience from Turkey. J Pediatr Endocrinol Metab. 2012;25:499-502.
  6. Marchand I, Barkaoui MA, Garel C, Polak M, Donadieu J. Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: Natural history and medical evaluation of 26 children and adolescents. J Clin Endocrinol Metab. 2011;96:e1352-60.
  7. Kobayashi T, Koga Y, Ishimura M, et al. Fever and skin involvement at diagnosis predicting the intractable Langerhans cell histiocytosis: 40 case-series in a single center. J Pediatr Hematol Oncol. 2018;40:e148-53.
  8. Varan A, Cila A, Akyuz C, Kale G, Kutluk T, Buyukpamukcu M. Radiological evaluation of patients with pituitary langerhans cell histiocytosis at diagnosis and at follow- up. Pediatr Hematol Oncol. 2008;25:567-74.
  9. Lau LMS, Stuurman K, Weitzman S. Skeletal Langerhans cell histiocytosis in children: Permanent consequences and health-related quality of life in long-term survivors. Pediatr Blood Cancer 2008;50:607-12. https://doi.org/10.1002/pbc.21322